Structures by: Wang Y. G.
Total: 54
C38H31N2O2PS
C38H31N2O2PS
Organic letters (2008) 10, 6 1267-1269
a=11.2087(5)Å b=12.0664(5)Å c=13.4025(6)Å
α=103.9954(13)° β=112.3908(10)° γ=97.9045(11)°
C42H37BrN3O4PS2
C42H37BrN3O4PS2
Organic letters (2008) 10, 6 1267-1269
a=9.9073(5)Å b=11.6315(4)Å c=17.0006(7)Å
α=85.2609(10)° β=85.6942(13)° γ=87.5166(13)°
C21H22N4O6
C21H22N4O6
Organic letters (2008) 10, 1 13-16
a=10.0212(7)Å b=11.0094(8)Å c=20.3173(16)Å
α=89.994(2)° β=85.467(2)° γ=75.5870(17)°
C31H34O8
C31H34O8
Organic letters (2006) 8, 6 1241-1244
a=11.573(3)Å b=14.732(4)Å c=17.032(5)Å
α=90.0000° β=98.886(11)° γ=90.0000°
C24H17NO
C24H17NO
Chemical communications (Cambridge, England) (2016) 52, 94 13664-13667
a=15.3015(18)Å b=12.1976(10)Å c=9.6252(8)Å
α=90.00° β=90.00° γ=90.00°
C42H48Co4N8O14
C42H48Co4N8O14
Dalton transactions (Cambridge, England : 2003) (2011) 40, 43 11402-11409
a=18.347(4)Å b=19.007(4)Å c=16.286(3)Å
α=90.00° β=121.66(3)° γ=90.00°
C44H60Cl4Co4N8O8
C44H60Cl4Co4N8O8
Dalton transactions (Cambridge, England : 2003) (2011) 40, 43 11402-11409
a=17.4477(8)Å b=17.4477(8)Å c=17.2562(16)Å
α=90.00° β=90.00° γ=90.00°
C96H110Cl2Co7N24O33
C96H110Cl2Co7N24O33
Dalton transactions (Cambridge, England : 2003) (2011) 40, 43 11402-11409
a=20.2022(10)Å b=20.2022(10)Å c=27.387(3)Å
α=90.00° β=90.00° γ=120.00°
C41.5H45Cl3N2PtSi2
C41.5H45Cl3N2PtSi2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 36 13092-13100
a=12.1068(4)Å b=18.3651(7)Å c=21.0217(7)Å
α=74.111(2)° β=77.900(2)° γ=81.188(2)°
C42H45N3PtSi2
C42H45N3PtSi2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 36 13092-13100
a=13.2821(3)Å b=30.6005(7)Å c=20.2538(4)Å
α=90.00° β=91.8230(10)° γ=90.00°
C40H41N2PtSi2,CHCl3
C40H41N2PtSi2,CHCl3
Dalton transactions (Cambridge, England : 2003) (2013) 42, 36 13092-13100
a=12.3245(5)Å b=18.1803(7)Å c=19.7378(8)Å
α=88.681(2)° β=74.458(2)° γ=79.431(2)°
C26H17BrN2Pt,2(CH2Cl2)
C26H17BrN2Pt,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 1 352-360
a=7.684(2)Å b=22.104(3)Å c=17.567(3)Å
α=90.00° β=95.756(2)° γ=90.00°
C26H17BrN2Pt,2(CHCl3)
C26H17BrN2Pt,2(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 1 352-360
a=7.7725(4)Å b=21.7699(12)Å c=18.8391(8)Å
α=90.00° β=94.510(2)° γ=90.00°
C15H13N5O5
C15H13N5O5
Dalton transactions (Cambridge, England : 2003) (2012) 41, 36 11107-11115
a=16.8753(14)Å b=8.0175(7)Å c=11.2187(9)Å
α=90.00° β=90.00° γ=90.00°
C16H15N5O5
C16H15N5O5
Dalton transactions (Cambridge, England : 2003) (2012) 41, 36 11107-11115
a=6.4252(5)Å b=13.5443(11)Å c=19.5352(16)Å
α=90.00° β=105.3640(10)° γ=90.00°
C64H56Cu2N20O20
C64H56Cu2N20O20
Dalton transactions (Cambridge, England : 2003) (2012) 41, 36 11107-11115
a=11.654(1)Å b=12.926(1)Å c=13.271(1)Å
α=76.991(1)° β=72.708(1)° γ=65.931(1)°
B4Cr8H8K5Na11O70P12
B4Cr8H8K5Na11O70P12
Dalton transactions (Cambridge, England : 2003) (2010) 39, 31 7262-7265
a=10.4633(9)Å b=15.0491(11)Å c=18.7214(15)Å
α=90.00° β=90.00° γ=90.00°
C46H44N10NiO12S2
C46H44N10NiO12S2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 21 7679-7692
a=23.030(9)Å b=9.674(3)Å c=22.455(9)Å
α=90.00° β=99.951(12)° γ=90.00°
C38H36N10NiO10
C38H36N10NiO10
Dalton transactions (Cambridge, England : 2003) (2013) 42, 21 7679-7692
a=9.0372(5)Å b=10.4058(5)Å c=11.1366(6)Å
α=73.1240(10)° β=74.2220(10)° γ=77.9910(10)°
C38H36CuN10O10
C38H36CuN10O10
Dalton transactions (Cambridge, England : 2003) (2013) 42, 21 7679-7692
a=9.443(5)Å b=9.828(7)Å c=11.689(7)Å
α=72.521(10)° β=69.916(9)° γ=78.602(9)°
C46H44CuN10O12S2
C46H44CuN10O12S2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 21 7679-7692
a=22.524(4)Å b=9.9036(16)Å c=22.397(4)Å
α=90.00° β=99.079(3)° γ=90.00°
C18H20Cl2Cu2N4O6,H2O
C18H20Cl2Cu2N4O6,H2O
Chemical communications (Cambridge, England) (2009) 34, 17 2396-2398
a=10.3787(2)Å b=6.6130(1)Å c=16.8336(2)Å
α=90.00° β=103.344(1)° γ=90.00°
C16H16N4O2
C16H16N4O2
CrystEngComm (2015) 17, 10 2083
a=7.3985(5)Å b=7.5160(5)Å c=13.5827(9)Å
α=100.7370(10)° β=93.4910(10)° γ=103.1710(10)°
C17H18N4O2
C17H18N4O2
CrystEngComm (2015) 17, 10 2083
a=8.0716(9)Å b=9.9236(12)Å c=11.1322(13)Å
α=65.8720(10)° β=80.149(2)° γ=74.023(2)°
C17H18N4O2,C16H16N4O2
C17H18N4O2,C16H16N4O2
CrystEngComm (2015) 17, 10 2083
a=7.811(2)Å b=12.550(4)Å c=16.146(5)Å
α=94.579(5)° β=91.539(4)° γ=98.774(5)°
C52H48Cl8Cu2N12O4
C52H48Cl8Cu2N12O4
Dalton transactions (Cambridge, England : 2003) (2014) 43, 37 13831-13834
a=12.946(2)Å b=13.680(2)Å c=19.492(4)Å
α=90.00° β=114.307(2)° γ=90.00°
C52H48Br8Cu2N12O4
C52H48Br8Cu2N12O4
Dalton transactions (Cambridge, England : 2003) (2014) 43, 37 13831-13834
a=12.949(10)Å b=14.283(12)Å c=19.337(12)Å
α=90.00° β=114.18(4)° γ=90.00°
C50H50Cl8Cu2N6O8,2(H2O)
C50H50Cl8Cu2N6O8,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 37 13831-13834
a=8.722(7)Å b=18.004(13)Å c=18.378(14)Å
α=90.00° β=99.404(10)° γ=90.00°
C52H48Cl8Cu2N12O4
C52H48Cl8Cu2N12O4
Dalton transactions (Cambridge, England : 2003) (2014) 43, 37 13831-13834
a=12.946(2)Å b=13.680(2)Å c=19.492(4)Å
α=90.00° β=114.307(2)° γ=90.00°
C52H48Br8Cu2N12O4
C52H48Br8Cu2N12O4
Dalton transactions (Cambridge, England : 2003) (2014) 43, 37 13831-13834
a=12.949(10)Å b=14.283(12)Å c=19.337(12)Å
α=90.00° β=114.18(4)° γ=90.00°
C50H50Cl8Cu2N6O8,2(H2O)
C50H50Cl8Cu2N6O8,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 37 13831-13834
a=8.722(7)Å b=18.004(13)Å c=18.378(14)Å
α=90.00° β=99.404(10)° γ=90.00°
C25H24ClN3O4
C25H24ClN3O4
Organic letters (2008) 10, 1 13-16
a=13.3036(7)Å b=16.2479(8)Å c=12.1618(6)Å
α=90.0000° β=114.9040(11)° γ=90.0000°
C20H17FO7,C3H6O
C20H17FO7,C3H6O
Acta Crystallographica Section E (2005) 61, 5 o1374-o1376
a=19.1786(9)Å b=7.7058(3)Å c=14.0757(7)Å
α=90° β=92.373(2)° γ=90°
1-[(4-Nitrophenoxy)acetyl]-3-(5-thioxo-4,5-dihydro-1,3,4-thiadiazolin-2-yl)urea dimethylformamide solvate
C11H9N5O5S2,C3H7NO
Acta Crystallographica Section E (2005) 61, 9 o3066-o3068
a=7.9981(12)Å b=11.3139(16)Å c=12.0232(17)Å
α=68.893(2)° β=70.744(2)° γ=70.897(2)°
1-(2,6-Difluorobenzoyl)-3-(5-1,3,4-thiadiazol-2-yl)urea
C10H6F2N4O2S
Acta Crystallographica Section E (2005) 61, 8 o2360-o2362
a=20.674(2)Å b=8.2442(9)Å c=14.9541(16)Å
α=90.00° β=111.106(2)° γ=90.00°
1-(2-Methylbenzoyl)-3-{5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl}urea
C18H13F3N4O2S
Acta Crystallographica Section E (2005) 61, 12 o4212-o4214
a=16.844(2)Å b=7.3080(11)Å c=15.202(2)Å
α=90.00° β=104.964(2)° γ=90.00°
2-(2,4-Dichlorophenoxy)-N-[5-(3-pyridyl)-1,3,4-thiadiazol-2-yl]acetamide
C15H10Cl2N4O2S
Acta Crystallographica Section E (2005) 61, 7 o2254-o2255
a=7.6550(7)Å b=9.0221(8)Å c=22.927(2)Å
α=90.00° β=92.811(2)° γ=90.00°
Pr3Cl1Si2O8
Pr3Cl1Si2O8
Acta Crystallographica Section C (1995) 51, 12 2471-2473
a=14.300(2)Å b=6.430(1)Å c=8.754(2)Å
α=90° β=98.36(2)° γ=90°
Dy1O19Ta7
Dy1O19Ta7
Acta Crystallographica Section C (1996) 52, 1 5-7
a=6.199(3)Å b=6.199(3)Å c=19.859(6)Å
α=90° β=90° γ=120°
1-[4-(Difluoromethoxy)phenyl]-<i>N</i>-(2,3-dimethylphenyl)-1<i>H</i>-1,2,4- triazole-3-carboxamide
C18H16F2N4O2
Acta Crystallographica Section E (2009) 65, 5 o1015-o1016
a=7.5543(10)Å b=7.8132(10)Å c=14.8190(19)Å
α=95.974(2)° β=98.5930(10)° γ=101.5230(10)°
Tris(2-ethyl-1<i>H</i>-imidazole-κ<i>N</i>^3^)(terephthalato-\ κ<i>O</i>)zinc(II)
C23H28N6O4Zn
Acta Crystallographica Section E (2009) 65, 5 m576
a=11.548(2)Å b=11.759(2)Å c=18.719(4)Å
α=90.00° β=91.79(3)° γ=90.00°
4,4'-Diformyltriphenylamine
C20H15NO2
Acta Crystallographica Section E (2009) 65, 9 o2192
a=8.836(2)Å b=9.710(2)Å c=18.621(4)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-6-methyl-1,3-benzothiazole--octanedioic acid (2/1)
2(C8H8N2S),C8H14O4
Acta Crystallographica Section E (2009) 65, 11 o2832
a=12.4372(12)Å b=7.9165(8)Å c=16.6061(12)Å
α=90.00° β=127.992(5)° γ=90.00°
2-Ethoxy-6-[(methylimino)methyl]phenol
C10H13NO2
Acta Crystallographica Section E (2010) 66, 7 o1526
a=9.2986(19)Å b=14.713(3)Å c=7.0551(15)Å
α=90.00° β=108.465(8)° γ=90.00°
1-[4-(Difluoromethoxy)phenyl]-<i>N</i>-(3,4-dimethoxyphenyl)-1<i>H</i>- 1,2,4-triazole-3-carboxamide
C18H16F2N4O4
Acta Crystallographica Section E (2010) 66, 9 o2267-o2268
a=9.4015(19)Å b=12.138(2)Å c=16.270(3)Å
α=77.345(2)° β=88.040(2)° γ=87.376(2)°
(5-Benzoyl-2-methyl-4-{[1-(pyridin-4-yl)-1<i>H</i>-1,2,3-triazol-4- yl]methoxy}-1-benzofuran-7-yl)(phenyl)methanone
C31H22N4O4
Acta Crystallographica Section E (2012) 68, 6 o1916
a=10.11(2)Å b=10.87(3)Å c=11.64(3)Å
α=94.73(4)° β=92.07(3)° γ=92.05(4)°
<i>N</i>-(2-Iodo-phenyl)-benzamidine
C13H11IN2
Acta Crystallographica Section E (2012) 68, 3 o726
a=10.411(3)Å b=11.024(3)Å c=11.534(3)Å
α=95.501(3)° β=95.065(3)° γ=102.986(3)°
10-Ethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-10<i>H</i>-phenothiazine
C17H15N3OS
Acta Crystallographica Section E (2012) 68, 3 o649
a=7.6752(4)Å b=8.2913(4)Å c=12.9469(8)Å
α=84.870(4)° β=82.569(4)° γ=63.696(3)°
4,5,6,7-Tetrachloro-<i>N</i>-(2,3,4-trifluorophenyl)phthalimide
C14H2Cl4F3NO2
Acta Crystallographica Section E (2011) 67, 7 o1604
a=6.7722(7)Å b=8.8052(12)Å c=24.493(3)Å
α=95.777(9)° β=94.514(17)° γ=98.839(12)°
2-(5-Bromothiophen-2-yl)-5-[5-(10-ethylphenothiazin-3-yl)thiophen-2-yl]- 1,3,4-oxadiazole
C24H16BrN3OS3
Acta Crystallographica Section E (2012) 68, 5 o1383-o1384
a=7.4300(5)Å b=7.6019(5)Å c=22.1933(14)Å
α=89.315(4)° β=89.170(4)° γ=64.891(4)°
C47H34F9LaN6O7
C47H34F9LaN6O7
Inorganic chemistry (2017) 56, 7 3889-3900
a=24.515(5)Å b=9.8624(19)Å c=19.371(4)Å
α=90° β=101.521(3)° γ=90°
C47H34EuF9N6O7
C47H34EuF9N6O7
Inorganic chemistry (2017) 56, 7 3889-3900
a=24.109(7)Å b=9.717(3)Å c=19.229(5)Å
α=90° β=102.483(5)° γ=90°
C49H39F9GdN7O7
C49H39F9GdN7O7
Inorganic chemistry (2017) 56, 7 3889-3900
a=25.785(5)Å b=9.6947(17)Å c=19.500(3)Å
α=90° β=96.132(4)° γ=90°
C49H39F9LaN7O7
C49H39F9LaN7O7
Inorganic chemistry (2017) 56, 7 3889-3900
a=25.9806(11)Å b=9.7415(4)Å c=19.6248(7)Å
α=90° β=95.2710(10)° γ=90°